Autonomous implantable devices without any external power input are desirable in many situations. Glucose fuel cells (GFCs) that rely on the use of glucose and oxygen available in human body fluids may power implanted medical devices. This work offers a new route to the development of abiotically catalyzed GFCs (AGFCs) with high performance. Herein, we report a new, easy, rapid, and inexpensive design (by-pass depletion design) to manufacture an AGFC based on synthesized Pt/rGO (anodic electrode) and Fe-Co/KB (cathodic electrode). Moreover, the feasibility and the performance of the AGFC in the presence of glucose as fuel has been investigated using three sources: idealized-buffer, simulated tissue fluid, and human blood serum (HBS); and oxygen is taken directly by an oxygen-selective cathode which is a great advantage to decrease the formation of mixed potential founded in these fuel cells. Electrochemical evaluations in HBS show that the fabricated AGFC can deliver a power density of ~12.5 ?Wcm-2 (at 230 mV and 54 ?Acm-2). Also, after 8 h of continuous operation in HBS under 10 ?Acm-2 discharge load, the AGFC still delivers ~50% of its initial power density, achieving a half-life well comparable to the state of the art devices. © 2022 Elsevier B.V
Ex vivo energy harvesting by a by-pass depletion designed abiotic glucose fuel cell operated with real human blood serum
Vizza F;
2022
Abstract
Autonomous implantable devices without any external power input are desirable in many situations. Glucose fuel cells (GFCs) that rely on the use of glucose and oxygen available in human body fluids may power implanted medical devices. This work offers a new route to the development of abiotically catalyzed GFCs (AGFCs) with high performance. Herein, we report a new, easy, rapid, and inexpensive design (by-pass depletion design) to manufacture an AGFC based on synthesized Pt/rGO (anodic electrode) and Fe-Co/KB (cathodic electrode). Moreover, the feasibility and the performance of the AGFC in the presence of glucose as fuel has been investigated using three sources: idealized-buffer, simulated tissue fluid, and human blood serum (HBS); and oxygen is taken directly by an oxygen-selective cathode which is a great advantage to decrease the formation of mixed potential founded in these fuel cells. Electrochemical evaluations in HBS show that the fabricated AGFC can deliver a power density of ~12.5 ?Wcm-2 (at 230 mV and 54 ?Acm-2). Also, after 8 h of continuous operation in HBS under 10 ?Acm-2 discharge load, the AGFC still delivers ~50% of its initial power density, achieving a half-life well comparable to the state of the art devices. © 2022 Elsevier B.VFile | Dimensione | Formato | |
---|---|---|---|
prod_462703-doc_180915.pdf
solo utenti autorizzati
Descrizione: Ex vivo energy harvesting by a by-pass depletion designed abiotic glucose fuel cell operated with real human blood serum
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
7.5 MB
Formato
Adobe PDF
|
7.5 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.